Stargardt's disease


Also found in: Wikipedia.

Stargardt's disease

 [stahr´gahrts]
a congenital form of macular degeneration that first appears between the ages of 6 and 20 and is marked by rapid loss of visual acuity with a cystlike macular lesion that in the early stages resembles egg yolk. Called also Stargardt's macular degeneration.

Stargardt's disease

A hereditary condition characterized by progressive retinal degeneration, due to a defect on chromosome 1; SD is similar to age-related macular degeneration. See Macular degeneration.
References in periodicals archive ?
Victoria, 31, has Stargardt's disease, an inherited eye disease which affects the macula.
Stargardt's disease and age-related macular degeneration are different diseases with similar symptoms.
a specialty pharmaceutical development company focused on ophthalmology announced today that the European Medicines Agency (EMA) has granted orphan drug designation for their lead candidate, MI-100, for the treatment of Stargardt's Disease.
A sober preface sets out an extensive series of degenerations, age-related macular degeneration (AMD), Stargardt's disease, retinitis pigmentosa and glaucoma, indicating the exciting approach to stem cell therapies.
Its lead product is undergoing studies in humans who have dry age-related macular degeneration and Stargardt's disease.
The Scots both suffer from a deteriorating eye condition called Stargardt's disease.
Smyth, who has limited vision because of Stargardt's disease, was not challenged as he burst from the blocks.
Boss was diagnosed with Stargardt's disease, a genetic disorder that led to blindness when she was just eight-years-old.
MVRF provides funding to leading researchers around the world who are working to find a cure for all retinal diseases, including LCA, Macular Degeneration, Stargardt's Disease, and others.
Advanced Cell Technologies, Marlborough, MA, reported the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has announced a positive opinion of the company's human embryonic stem cell (hESC)derived retinal pigment epithelial (RPE) cells for designation as an orphan medical product for the treatment of Stargardt's disease.
McKeever, who suffers from Stargardt's disease and is legally blind, effectively booked his place on the 11-member squad by winning an able-bodied 50-km race in Canmore, Alberta last month.
One glimmer of hope on the horizon is the news that clinical trials for the treatment for Stargardt's disease could start next spring after an American company applied for permission to proceed with the trials last month.